Vascular alternatives used in hemodialysis

Authors

Keywords:

Vascular access, hemodialysis, arteriovenous fistula, catheter, synthetic graft

Abstract

Hemodialysis requires effective and long-lasting vascular access to ensure proper removal of toxins and fluids. This study aims to analyze vascular accesses for hemodialysis and their relationship with individual and pathological conditions that generate the need for temporary or permanent access. This critical review analyzes the main vascular access options: arteriovenous fistula, synthetic grafts and central venous catheters. It addresses their advantages, disadvantages, complication rates and clinical selection criteria. The collection and analysis of information was carried out according to the guidelines established by the PRISMA model. To ensure the quality and reliability of the literature review, scientific articles, books and up-to-date documents from specialized journals were selected, while theses, abstracts and unaccredited sources on the web were excluded. An advanced search was conducted in PubMed Central, SciELO, Google Scholar, Embase and Science, which enabled a structured compilation of knowledge on vascular accesses for hemodialysis and their main complications. Literature indicates that arteriovenous fistulas remain the preferred option due to higher survival rates and lower infection risks, although they may take longer to mature. Grafts are a suitable alternative when fistulas are not feasible, while catheters are generally reserved for urgent situations. The review highlights the importance of an individualized approach based on the patient’s vascular status and prognosis. An appropriate selection  improves quality of life and reduces complications associated with hemodialysis.

Downloads

Download data is not yet available.

References

Acosta Arias Y. Caracterización de los pacientes con fístulas arterio-venosas para hemodiálisis. Rev Cubana Angiol Cir Vasc . 2021 [citado 20/08/2025];22(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1682-00372021000100002&lng=es.

Yuo TH, Oliver MJ. Central venous catheters for acute and chronic hemodialysis access and their management. 2025. [citado 20/08/2025]. Disponible en: https://www.uptodate.com/contents/central-venous-catheters-for-acute-and-chronic-hemodialysis-access-and-their-management

Schmidt RJ, Flythe JE. Overview of the hemodialysis apparatus. 2025. [citado 20/08/2025]. Disponible en: https://www.uptodate.com/contents/overview-of-the-hemodialysis-apparatus

Juárez Crespo C, Tascón Quevedo V, García Martínez B, Kislikova M. Accesos vasculares para diálisis. Peripheral vascular surgery review: Peripherical vascular access. Cirugía Cardiovascular. 2024. [citado 20/08/2025];31(4):175-182.Disponible en: https://www.sciencedirect.com/science/article/pii/S1134009624000974

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024 [citado 20/08/2025];105(4S):S117–S314. Disponible en: https://www.sciencedirect.com/science/article/pii/S0085253823007664?via%3Dihub

Nissenson AR, Fine RN. Manual de diálisis. 4ª ed. Madrid: Elsevier España; 2010. Disponible en:

https://books.google.es/books?hl=es&lr=&id=JLiaDQAAQBAJ&oi=fnd&pg=PA9&dq=acce sos+vasculares+para+hemodi%C3%A1lisis&ots=dkTciAFhB1&sig=nWIxhEYASSxnT7e3Q PIjKqYlepY#v=onepage&q=accesos%2520vasculares%2520para%2520hemodi%C3%A1lisi s&f=false

Lok CE, Huber TS, Orchaniam-Cheff A, Rajan DK. Arteriovenous Access for Hemodialysis: A Review. JAMA. 2024;331(15):1307-1317.

Wu H, Li Q, Fan L, Krämer B, Lianghong Y, Fanna L,et al. Prognostic Value of Serum Magnesium in Mortality Risk among Patients on Hemodialysis: A Meta-Analysis of Observational Studies. Kidney Dis (Basel) 2020 [citado 20/08/2025];7(1):24–33.Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7879293/pdf/kdd-0007-0024.pdf

Charytan DM, Winkelmayer WC, Granger CB, Whitson JD, Eudicone JM,Herzog CA,et al. Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia. Kidney Int 2025 [citado 20/08/2025];107(1):169-179. Disponible en: https://pubmed.ncbi.nlm.nih.gov/39490411/

Dillavou ED, Lucas JF, Woodside K. VasQ U.S. pivotal study demonstrates the safety and effectiveness of an external vascular support for arteriovenous fistula creation. J Vasc Surg 2023 [citado 20/08/2025];78:1302.

Shahverdyan R, Tabbi P, Mestres G. Multicenter European real-world utilization of VasQ anastomotic external support device for arteriovenous fistulae. J Vasc Surg. 2022 [citado 20/08/2025];75:248.

van Baarle FL, van de Weerdt EK, van der Velden WJ. Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia. N Engl J Med. 2023 [citado 20/08/2025]; 388:1956.

Chen Q, He Y, Zhao Y, Chen L. Intervening oxidative stress integrated with an excellent biocompatibility of hemodialysis membrane fabricated by nucleobase-recognized co- immobilization strategy of tannic acid, looped PEtOx brush and heparin. Journal of Membrane Science. 2021 [citado 20/08/2025];625:119174.

Lu C, Wang Y, Wang D. Hypomagnesemia and Short-Term Mortality in Elderly Maintenance Hemodialysis Patients. Kidney Dis (Basel) 2020 [citado 20/08/2025];6:109.

StoeckerJB, Clark TW, Mantell MP, Trerotola SO, Vance AZ.Dialysis access– associated steal syndromeandmanagement.Cardiovasc Intervent Radiol. 2023 [citado 20/08/2025];46(9):1168- 1181.

Published

2025-11-14

How to Cite

1.
Valencia Herrera AR, Bohórquez Rivera DS, López Illescas DE, Acurio Padilla iedad E. Vascular alternatives used in hemodialysis . CCM [Internet]. 2025 Nov. 14 [cited 2026 Feb. 12];29:e5420. Available from: https://revcocmed.sld.cu/index.php/cocmed/article/view/5420